Panobinostat [panobinostat]
topical
5
- Terms
-
Farydak
-
Farydak
LBH 589
LBH589
NVP-LBH589
Persistent link
https://www.medvik.cz/link/D000077767
Definition
An indole and hydroxamic acid derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used as an antineoplastic agent in combination with BORTEZOMIB and DEXAMETHASONE for the treatment of MULTIPLE MYELOMA.
- DUI
- D000077767 MeSH Browser
- CUI
- M0540392
- CAS
- 2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino) methyl)phenyl)-, (2E)-
- History note
- 2019 (2005)
- Public note
- 2019; PANOBINOSTAT was indexed under HYDROXAMIC ACIDS and INDOLES 2005-2018
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 1
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.633.100.473.250
Delavirdine
D03.633.100.473.278
Duocarmycins
D03.633.100.473.385
Hydroxytryptophol
D03.633.100.473.416
Indolosesquiterpenes
D03.633.100.473.432
Indoramin
D03.633.100.473.469
Iprindole
D03.633.100.473.629
Molindone
D03.633.100.473.725
Oxyphenisatin Acetate
D03.633.100.473.840
Sporidesmins